Janssen Pharma Drug Patent Portfolio

Janssen Pharma's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Janssen Pharma News

The Drug Price Negotiation Program implemented by the Federal Government may potentially breach its own regulations...

26 Jan, 2026

Janssen Pharmaceuticals, Inc. vs. Teva Pharmaceuticals USA, Inc. - Q3 2025 | Robins Kaplan LLP - JDSupra

21 Oct, 2025

See More